A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine
Clinical Psychopharmacology and Neuroscience
;
: 134-138, 2019.
Article
in English
| WPRIM
| ID: wpr-739462
ABSTRACT
Rabbit Syndrome is an uncommon side effect of antipsychotic treatment. Although it is usually associated with typical antipsychotics, it can also be related to atypical antipsychotics. Anticholinergics are the most accepted treatment approach in treating Rabbit Syndrome. Fluvoxamine is a member of selective serotonin reuptake inhibitors and it is a potent agonist of sigma 1 receptors. In this article, we report a Rabbit Syndrome case who has benefited from fluvoxamine, in terms of both depressive disorder and Rabbit Syndrome; and present the data on the effects of sigma 1 agonist fluvoxamine on numerous movement disorders.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Antipsychotic Agents
/
Fluvoxamine
/
Selective Serotonin Reuptake Inhibitors
/
Receptors, sigma
/
Cholinergic Antagonists
/
Depressive Disorder
/
Movement Disorders
Language:
English
Journal:
Clinical Psychopharmacology and Neuroscience
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS